|
|
||||||||
Papers In Press, published online ahead of print January 29, 2007
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Cell Chemistry, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Okayama 700-8558
Corresponding Author: eijimatu{at}md.okayama-u.ac.jp
C-reactive protein (CRP) is one of the strongest independent predictor of cardiovascular disease (CVD). We have previously reported that oxidized LDL (oxLDL) interacts with ß2-glycoprotein I (ß2GPI), implicating oxLDL/ß2GPI complexes as putative autoantigens in autoimmune-mediated atherosclerotic vascular disease. In this study, we investigated the interaction of CRP with oxLDL/ß2GPI complexes and its association with atherosclerosis in patients with diabetes mellitus (DM). CRP/oxLDL/ß2GPI complexes were predominantly found in sera of DM patients with atherosclerosis. In contrast, non-complexed CRP isoforms were present in sera of patients with acute/chronic inflammation, i.e., various pyrogenic diseases, rheumatoid arthritis (RA), and DM. Immunohistochemistry staining co-localized CRP and ß2GPI together with oxLDL in carotid artery plaques but not in synovial tissue from RA patients, strongly suggesting that complex formation occurs during the development of atherosclerosis. Serum levels of CRP correlated with soluble forms of ICAM-1 and VCAM-1, and oxLDL/ß2GPI complexes correlated with total cholesterol and hemoglobin A1c. Thus, the generation of CRP/oxLDL/ß2GPI complexes seems to be associated with arterial inflammation, hyperglycemia, and hypercholesterolemia. CRP/oxLDL/ß2GPI complexes can be distinguished from pyrogenic non-complexed CRP isoforms and may represent a more specific and predictive marker for atherosclerosis.
Revised on January 16, 2007
Accepted on January 28, 2007
The association of C-reactive protein with an oxidative metabolite of LDL and its implication in atherosclerosis
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
P. R. J. Ames, I. Antinolfi, A. Ciampa, J. Batuca, G. Scenna, L. R. Lopez, J. Delgado Alves, L. Iannaccone, and E. Matsuura Primary antiphospholipid syndrome: a low-grade auto-inflammatory disease? Rheumatology, December 1, 2008; 47(12): 1832 - 1837. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |